Safety & Immune Response of Novartis of MenACWY Conjugate Vaccine When

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Prevention

See also
Status	Clinical Trial	Phase
Completed	`NCT00774384` - Regulation of Mucosal Immune Response to Systemic MenB Vaccine	Phase 2
Completed	`NCT00450632` - Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection	N/A
Completed	`NCT00874549` - Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 Years	Phase 1/Phase 2
Completed	`NCT00850603` - Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®	Phase 4
Completed	`NCT02591290` - Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects	Phase 4
Completed	`NCT03378258` - Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.
Completed	`NCT01482052` - Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis	Phase 1
Completed	`NCT01239043` - Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination	Phase 2
Completed	`NCT01732627` - Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older	Phase 2
Not yet recruiting	`NCT05212935` - A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy
Completed	`NCT00474487` - A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults	Phase 3
Completed	`NCT02041663` - Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis	N/A
Completed	`NCT03205358` - Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers	Phase 2
Completed	`NCT00450437` - A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults	Phase 3
Completed	`NCT03798574` - The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults
Completed	`NCT02640404` - Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam	Phase 2
Recruiting	`NCT05981599` - Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease
Completed	`NCT02500511` - Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study	N/A
Completed	`NCT02199691` - Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents	Phase 2
Completed	`NCT02864927` - Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea	Phase 4

NCT number	NCT00616421
Study type	Interventional
Source	Novartis
Contact
Status	Completed
Phase	Phase 3
Start date	March 2008
Completion date	October 2009

Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms